Tech Center 1600 • Art Units: 1641 1642 1677 1678
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17469533 | METHODS FOR DETECTING AND QUANTIFYING MEMBRANE-ASSOCIATED PROTEINS | Final Rejection | GENENTECH, INC. |
| 17945398 | METHOD TO PREVENT SAMPLE PREPARATION-INDUCED DISULFIDE SCRAMBLING IN NON-REDUCED PEPTIDE MAPPING | Non-Final OA | Regeneron Pharmaceuticals, Inc |
| 17934950 | PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION | Final Rejection | KASHIV BIOSCIENCES, LLC |
| 18460254 | METHODS AND DEVICES FOR ASSAYING A BIOLOGICAL SAMPLE | Final Rejection | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 17901294 | SYSTEM AND SENSOR ARRAY | Non-Final OA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 17769533 | MULTIPLE ANALYTE FECAL ANTIGEN TESTING | Final Rejection | Exact Sciences Corporation |
| 17442782 | BIOMARKER WITH THERAPEUTIC IMPLICATIONS FOR PERITONEAL CARCINOMATOSIS | Final Rejection | SINGAPORE HEALTH SERVICES PTE LTD |
| 18473207 | PROTEIN SEQUENCING METHOD AND REAGENTS | Final Rejection | The Governing Council of the University of Toronto |
| 17914282 | REAGENT COMPRISING ANTIBODY FROM WHICH PART OF Fc REGION IS DELETED | Final Rejection | Denka Company Limited |
| 18256516 | Biomarkers for Detecting Cancer | Non-Final OA | University of Cape Town |
| 17620186 | ASSESSMENT OF DISEASE RISK FACTORS IN CORRELATION WITH NEU5GC INGESTED IN FOOD | Final Rejection | RAMOT AT TEL AVIV UNIVERSITY LTD. |
| 18153965 | VEGF and TIE2-Binding Fusion Protein and Uses Thereof | Non-Final OA | INGENIA Therapeutics Inc. |
| 18002114 | Methods For Identification of Cognate Pairs of Ligands and Receptors | Non-Final OA | HiFiBio (HK) Limited |
| 17921275 | BIOMARKERS FOR DETECTION OF LUNG CANCER | Non-Final OA | The Translational Genomics Research Institute (TGEN) |
| 17789163 | Method for Purifying Biologically Active Peptide by Using Protein A Affinity Chromatography | Non-Final OA | ABL BIO INC. |
| 17788632 | PROGNOSTIC BIOMARKER OF CANCER | Final Rejection | Yuko HASHIMOTO |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy